SCHEMBL22947412

SCHEMBL22947412

Clc1ccc(-c2ccc3c(c2)S(c2ccccc2)(c2ccccc2)c2ccccc2-3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
PDK2 Q15119 1/20 0.39
MAP4K4 O95819 1/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
APAF1 O14727 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39
PTBP1 P26599 1/20 0.39
RAB9A P51151 1/20 0.39
GALK1 P51570 1/20 0.39
BLM P54132 1/20 0.39
SMAD3 P84022 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947628 0.88 PDK2 (0.36) CYP1A2PDK2SMN1; SMN2MEN1NPC1
SCHEMBL22941730 0.86 S100A4 (0.40) PDK2MAP4K4SMN1; SMN2NPC1RAB9A
SCHEMBL22947475 0.86 CYP1A2 (0.37) CYP1A2PDK2MAP4K4HTTSMN1; SMN2
SCHEMBL22947588 0.84 CYP1A2 (0.41) CYP1A2PDK2MAP4K4HTTSMN1; SMN2
SCHEMBL22947689 0.84 CYP2A6 (0.46) PDK2AHR
SCHEMBL22947624 0.84 CYP2A6 (0.40) CYP1A2PDK2MAP4K4HTTMEN1
SCHEMBL22947646 0.81 MEN1 (0.40) HTTSMN1; SMN2MEN1APAF1NPC1
SCHEMBL21310622 0.81 MAPT (0.40) CYP1A2PDK2HTTSMN1; SMN2MEN1
SCHEMBL22947695 0.81 MEN1 (0.40) HTTSMN1; SMN2MEN1APAF1NPC1
SCHEMBL22947542 0.78 CYP1A2 (0.43) CYP1A2PDK2MAP4K4HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CYP1A2 281/4885PDK2 1353/4885MAP4K4 3573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.